References
5-
Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients.
Am J Transplant. 2009;9 Suppl 3:S1-155.
6-
Solez K,
Colvin RB,
Racusen LC,
Sis B,
Halloran PF,
Birk PE,et al.Banff-05meeting report: differential diagnosis of chronic allograft injury andelimination of chronic allograft nephropathy (CAN).
Am J Transplant. 2007;7(3):518-26.
7-
Solez K,
Colvin RB,
Racusen LC,
Haas M,
Sis B,
Mengel M , et al: Banff 07 classification of renalallograft pathology: updates and future directions.
Am J Transplant. 2008;8(4):753-60
8- Fernandez-Fresnedo G, Plaza JJ, Sanchez-Plumed J, et al:Proteinuria: a new marker of long-term graft and patient survival inkidney transplantation. Nephrol Dial Transplant 2004;19(Suppl 3):iii47,
9- Amer H, Fidler ME, Myslak M, et al: Proteinuria after kidneytransplantation, relationship to allograft histologyandsurvival.Am J Transplant 2007;7:2748.
10- Chapman JR, O’Connell PJ, Nankivell BJ. Chronic renal allograftdysfunction.
J Am Soc Nephrol. 2005;16(10):3015-26
11-
Serón D,
Moreso F,
Ramón JM,
Hueso M,
Condom E,
Fulladosa X , et al.Protocol renal allograftbiopsiesandthe design of clinical trials aimed to prevent or treatchronic allograft nephropathy.
Transplantation. 2000;69(9):1849-55.
12- B. H. Özdemir, A. A. Özdemir, T. Colak, S. Sezer, and M. Haberal, “The influence of tubular phenotypic changes on the development of diffuse interstitial fibrosis in renal allografts,” Transplantation Proceedings 2011; vol. 43, no. 2, pp. 527–529.
13-
Halimi JM,
Buchler M,
Al-Najjar A,
Laouad I,
Chatelet V,
Marlière JF, et al. Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients.
Am J Transplant. 2007;7(3):618-25.
14-
Amer H,
Fidler ME,
Myslak M,
Morales P,
Kremers WK,
Larson TS , et al. Proteinuria after kidney transplantation, relationship to allograft histology and survival.
Am J Transplant. 2007;7(12):2748-56.
15- Knoll GA. Proteinuria in kidney transplant recipients: prevalence, prognosis, and evidence-based management. Am J Kidney Dis. 2009;54:1131-44.
16-
Amer H,
Fidler ME,
Myslak M,
Morales P,
Kremers WK,
Larson TS, et al. Proteinuria after kidney transplantation relationship to allograft histology and survival.
Am J Transplant. 2007;7(12):2748-56 .
17-
Vathsala A,
Verani R,
Schoenberg L,
Lewis RM,
Van Buren CT,
Kerman RH, et al. Proteinuria in cyclosporinetreated renal transplant recipients. Transplantation 1990;49(1): 35–41.
18-
Yakupoglu U,
Baranowska-Daca E,
Rosen D,
Barrios R,
Suki WN,
Truong LD. Post-transplant nephrotic syndrome: A comprehensiveclinicopathologic study. Kidney Int.2004;65(6): 2360–70.
19-
Chung J,
Park SK,
Park JS,
Kim SC,
Han DJ,
Yu E. Glomerulonephritisis the major cause of proteinuria in renal transplantrecipients: Histopathologic findings of renal allografts with proteinuria. Clin Transplant 2000;14(5): 499–504.
20-
Pérez Fontán M,
Rodríguez-Carmona A,
García Falcón T,
Valdés F. Early proteinuria in renal transplant recipients treated with cyclosporin.Transplantation 1999;67(4): 561–8.
